Amarin shares pump up on positive results from cardiovascular study
Amarin Corporation (AMRN) announced positive results from a clinical study in which Vascepa, an EPA drug, was used to treat about 8,200 patients suffering from cardiovascular diseases. The study named … Continue reading Amarin shares pump up on positive results from cardiovascular study
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed